Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
LLYLilly (Eli)
FinDog View：Bullish
| Metric | GILD | LLY |
|---|
| Close | 147.68 | 1,137.82 |
| Market Cap | $183B | $1.07T |
| 1M | +6.31% | −3.83% |
| P/E (TTM) | — | 39.9 |
| Forward P/E | 25.3 | 28.5 |
| P/E 5-Yr Percentile | — | 6 |
| P/S | 6.0 | 13.4 |
| P/B | 15.3 | 31.5 |
| Dividend Yield | 3.98% | 0.75% |
| Latest Quarter Revenue | $7.8B | $23.0B |
| Revenue YoY | +10.2% | +47.7% |
| Gross Margin | 79.8% | 85.8% |
| Latest Quarter EPS | -8.45 | 7.94 |
| Avg Post-Earnings Move | ±3.8% | ±3.5% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.01% | 1.12% |
| 90-Day Net Insider Buying | −$15.4M | −$16.0M |
GILD · Revenue, Last 8 Quarters ($B)
LLY · Revenue, Last 8 Quarters ($B)
